Imagine...
a world where new therapies can be discovered and developed in a fraction of what it takes now.

How can we help?

Drug Discovery

The Cytocast™ Simulated Cell is an innovative platform designed to predict drug side effects by simulating billions of molecular interactions within human cells. Relying on a wide range of available information on how complex cellular processes work, our solution has the potential to revolutionize drug discovery by accelerating the overall process, reducing costs, and increasing clinical trial success rates.

Cytocast™ Simulated Cell

Precision medicine

Cytocast™ Digital Twin technology is currently in development at Cytocast. It is poised to play a pivotal role in enabling data-driven, personalized care that tailors treatments to patients based on their distinctive molecular characteristics, covering a wide range of therapeutic domains. Our approach to precision medicine development leverages multi-omics, single-cell, and patient data to gain a comprehensive understanding of how perturbations, such as diseases or drugs, impact cellular health in a personalized manner.

Cytocast™ Digital Twin

People and Values

Cytocast is an emerging TechBio startup based in Budapest that specializes in data-driven medical technology. We leverage this data to add value and achieve impactful results.

OUR VALUES

We are proud to be a company with a curious mindset and a strong research orientation. What sets us apart is the way we integrate multi-omics data, extensive scientific knowledge, expertise, high-performance computing, and cutting-edge data science methods to maximize insights into patient biology and accelerate the pace of drug discovery and development. We also have the privilege of working with numerous collaborative partners. We value these partnerships and recognize their importance in advancing our mission.

MAKE MEDICINE BETTER WITH ADVANCED CELL SIMULATION TECHNOLOGY

THE TEAM

At Cytocast, we believe in creative solutions and in the power of teamwork in a familiar atmosphere. Many of our team members have university affiliations continually exploring new possibilities.

How we do it

Cytocast is using computer simulations to determine the most effective treatment for patients while minimazing potential side effects

0

Proteins per simulation

0

Protein-protein interactions

0

Binding sites per simulation

0

Nr. of cell types

News

Cytocast Secures 1.65M Euros in Second Investment Round to Accelerate Innovation and Growth

2023-08-01

We are thrilled to announce that we have successfully secured our second investment round...

Cytocast at the Hungarian Molecular Life Science Conference

2023-03-27

Cytocast team recently participated in the Hungarian Molecular Life Science Conference held in Eger. The conference...

Cytocast is part of Central Europe Deeptech Startup Map

2022-10-17

Cytocast has been accepted to be part of the Central Europe Deeptech Startup Map. We are...

Interested in a demo?

Get in touch today to see how the Cytocast platform works.

Imagine...a world where new therapies can be discovered and developed in a fraction of what it takes now.